FDA approves colonoscopy alternative developed at Mayo Clinic

Author:
Updated:
Original:

The U.S. Food and Drug Administration approved a new, noninvasive test that screens for colon cancer.

KARE reports the screening test, called Cologuard, was developed by the Mayo Clinic and Exact Sciences. The take-home, stool DNA test could be given to patients instead of a colonoscopy and could revolutionize the screening process for colon cancer.

It is the first such test to have sensitivity rates comparable to a colonoscopy, according to a study published earlier this year in the New England Journal of Medicine. The study found that the test is reliable in identifying potentially fatal colon cancers without requiring the prep work or an invasive procedure. The Mayo Clinic study found that the test was 92 percent accurate at identifying patients with colon cancer, and 69 percent accurate at identifying patients with the bowel lesions or polyps that indicate a high risk for cancer.

The Star Tribune previously reported the new test requires people to send stool samples in the mail for laboratory analysis. The sample would be checked for the presence of red blood cells and DNA mutations.

The screening test could become an option for patients who are squeamish about the exam or concerned about its cost, said Dr. David Ahlquist, a Mayo gastroenterologist and co-inventor of the Cologuard system.

Cologuard is available to patients through their healthcare providers in the U.S. for $599.

A press release from Exact Science published on the Wall Street Journal site said the Mayo Clinic has licensed the technology to Madison-based Exact Sciences, which has plans to make Cologuard available in select countries in Europe. Under a licensing agreement, Mayo Clinic and Dr. Ahlquist share in equity and royalties. Revenue Mayo Clinic receives is used to support Mayo's not-for-profit mission in patient care, education and research.

Next Up

Cam Talbot / Minnesota Wild

Wild take Game 1 over Vegas in overtime thriller

It was an epic dual between Cam Talbot and Marc-Andre Fluery.

Taylor Rogers

Twins defense, bullpen squanders another rally

This is the story of the 2021 Twins.

Minneapolis police

3 Mpls officers injured on night of shootings, stabbings and fights

It was a tense weekend for the city of Minneapolis.

Fruen Mill in Minneapolis.

Teen in serious condition after fall at abandoned Minneapolis mill

Multiple urban explorers have been hurt at the Fruen Mill.

Screen Shot 2021-04-12 at 5.44.29 PM

Brooklyn Center City Council votes to create department for noncriminal calls

The resolution is named after Daunte Wright and Kobe Dimock-Heisler, who were both killed by police in Brooklyn Center.

Screen Shot 2021-05-16 at 7.54.26 AM

Train derails while passing by lake in Albert Lea

The Union Pacific train derailed Saturday afternoon.

Kaprizov, Wild

5 questions for the Wild's playoff series against Vegas

The Wild seem to have the advantage, but can they win their first playoff series since 2015?

police tape, crime scene

Young girl shot in the head in north Minneapolis

The girl was outside when she was struck by the bullet, police said.

prison, Rush City cell block

Former Army Green Beret and U of M student sentenced for Russian espionage

Peter Rafael Dzibinski Debbins, 46, was sentenced to 188 months in prison.

Miguel Sano

Miguel Sanó's 8th inning blast ends Twins losing streak

The 5-4 victory over the A's snapped a five-game losing streak.

Related